Ilyang’s novel antiviral compounds presented at international conference

Data of new antiviral compounds, which were jointly developed by Ilyang Pharmaceutical and Hallym University, was presented at the 31st annual meeting of the American Society for Virology on July 22 at the University of Wisconsin-Madison in the U.S.

According to Ilyang officials, animal tests have shown that the new compound has a broad antiviral spectrum against influenza A and is more effe...